Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,008 public trials 572 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Symbenda Post-Marketing Surveillance (PMS)

NCT02434484

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations
  • Eisai Trial Site #7 Busan, South Korea
  • Eisai Trial Site #8 Busan, South Korea
  • Eisai Trial Site #6 Daegu, South Korea
  • Eisai Trial Site #4 Daejeon, South Korea
View Trial Details
Completed

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

NCT01380106

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Central Arkansas Veterans Healthcare System Little Rock, Arkansas, United States
  • West Los Angeles VA Medical Center Los Angeles, California, United States
  • Edward Hines Jr VA Hospital Hines, Illinois, United States
  • VA Boston Healthcare System Jamaica Plain, Massachusetts, United States
View Trial Details
Completed

A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

NCT00621244

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia Augusta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center/University of Texas Houston, Texas, United States
  • Novartis Investigative Site Parkville, Victoria, Australia
View Trial Details
Completed

Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year

NCT00424983

Conditions
Blood Protein Disorders, Breast Cancer, Breast Diseases, +18 more
Locations
  • Oncotherapeutics West Hollywood, California, United States
  • Rocky Mountain Cancer Centers RMCC Greenwood Village, Colorado, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.

NCT00532675

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UCSF Medical Center San Francisco, California, United States
  • Emory University School of Medicine/Winship Cancer Institute Dept. of Winship Cancer Inst. Atlanta, Georgia, United States
  • St. Vincent's Comprehensive Cancer Center New York, United States
  • Novartis Investigative Site South Brisbane, Queensland, Australia
View Trial Details

Related conditions